BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Malaguarnera G, Vacante M, Drago F, Bertino G, Motta M, Giordano M, Malaguarnera M. Endozepine-4 levels are increased in hepatic coma. World J Gastroenterol 2015; 21(30): 9103-9110 [PMID: 26290636 DOI: 10.3748/wjg.v21.i30.9103]
URL: https://www.wjgnet.com/1007-9327/full/v21/i30/9103.htm
Number Citing Articles
1
Giulia Malaguarnera, Gaetano Bertino, Giuseppe Chisari, Massimo Motta, Michele Vecchio, Marco Vacante, Filippo Caraci, Carmela Greco, Filippo Drago, Giuseppe Nunnari, Michele Malaguarnera. Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work abilityBMC Psychiatry 2016; 16(1) doi: 10.1186/s12888-016-1115-z
2
Giulia Malaguarnera, Manuela Pennisi, Gaetano Bertino, Massimo Motta, Antonio Borzì, Enzo Vicari, Rita Bella, Filippo Drago, Michele Malaguarnera. Resveratrol in Patients with Minimal Hepatic EncephalopathyNutrients 2018; 10(3) doi: 10.3390/nu10030329
3
A.R. Jayakumar, Michael D. Norenberg. Hyperammonemia in Hepatic EncephalopathyJournal of Clinical and Experimental Hepatology 2018; 8(3) doi: 10.1016/j.jceh.2018.06.007
4
Flavia Lambertucci, Omar Motiño, Uxía Nogueira-Recalde, Yan Rong, Léa Montégut, María Pérez-Lanzón, Vincent Carbonnier, Sijing Li, Sylvère Durand, Fanny Aprahamian, Hui Chen, Yanbing Dong, Allan Sauvat, Silvia Mingoia, Sylvie Lachkar, Ester Saavedra, Jonathan Pol, Federico Pietrocola, Maria Chiara Maiuri, Estela Rocha-Oliveira, Roberto Roncon-Albuquerque, Francisco Vasques-Nóvoa, Roberto Lozano-Rodríguez, José Avendaño-Ortiz, Eduardo López-Collazo, Mahmoud Abdellatif, Isabelle Martins, Guido Kroemer. Acyl-CoA-binding protein (ACBP): a poor-prognosis biomarker in sepsis and a target for disease mitigationSignal Transduction and Targeted Therapy 2026; 11(1) doi: 10.1038/s41392-026-02670-z
5
Giulia Malaguarnera, Vito Emanuele Catania, Gaetano Bertino, Laura Maria Chisari, Maria Castorina, Claudia Bonfiglio, Omar Cauli, Michele Malaguarnera. Acetyl-L-carnitine Slows the Progression from Prefrailty to Frailty in Older Subjects: A Randomized Interventional Clinical TrialCurrent Pharmaceutical Design 2022; 28(38) doi: 10.2174/1381612828666220830092815
6
Pan Zhao, Yanling Zhao, Zhenman Wei, Jing Chen, Lilong Yan. Wernicke encephalopathy in a patient with liver failureMedicine 2016; 95(27) doi: 10.1097/MD.0000000000003651
7
Manuela Pennisi, Gaetano Bertino, Caterina Gagliano, Michele Malaguarnera, Rita Bella, Antonio Borzì, Roberto Madeddu, Filippo Drago, Giulia Malaguarnera. Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep DisturbanceNutrients 2017; 9(8) doi: 10.3390/nu9080897
8
Giulia Malaguarnera, Vito Emanuele Catania, Claudia Bonfiglio, Gaetano Bertino, Enzo Vicari, Michele Malaguarnera. Carnitine Serum Levels in Frail Older SubjectsNutrients 2020; 12(12) doi: 10.3390/nu12123887
9
Gaetano Bertino, Dario Mangano, Emanuele Bertino, Adriana Toro, Isidoro Di Carlo, Vito Emanuele Catania, Mariano Malaguarnera, Nicoletta Bertino, Giulia Malaguarnera, Maria Irene Ruggeri, Evelise Frazzetto, Giuseppe Rigano, Maria Proiti, Annalisa Ardiri, Michele Malaguarnera, Carla Loreto, Venerando Rapisarda. Hepatocellular carcinoma and the risk of occupational exposureWorld Journal of Hepatology 2016; 8(13): 573-590 doi: 10.4254/wjh.v8.i13.573
10
Giulia Malaguarnera, Gaetano Bertino, Carmela Greco, Caterina Gagliano, Massimo Motta, Giuseppe Chisari, Venerando Rapisarda, Giuseppe Nunnari, Michele Vecchio, Filippo Drago, Michele Malaguarnera. Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational studyTranslational Medicine Communications 2017; 2(1) doi: 10.1186/s41231-016-0010-4
11
Vito Emanuele Catania, Giulia Malaguarnera, Giorgia Fiorenza, Eleonora Margherita Chisari, Anna Rita Lipari, Valentino Gallina, Manuela Pennisi, Giuseppe Lanza, Michele Malaguarnera. Hepatitis C Virus Infection Increases Fatigue in Health Care WorkersDiseases 2020; 8(4) doi: 10.3390/diseases8040037